Combined Use of Machine Learning and Metabolomics to Improve the Diagnosis and Management of Hyperandrogenism
NCT ID: NCT07253454
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
800 participants
OBSERVATIONAL
2026-01-31
2040-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is also responsible for infertility. As a reminder, infertility is a major public health issue and affects more and more couples around the world.
The investigators therefore wish to develop innovative tools to improve the diagnosis and management of hyperandrogenism
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Hyperandrogenism in Type 1 Diabetes
NCT04979377
Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
NCT05555680
Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls
NCT00928759
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
NCT03911297
Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation
NCT01421797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is also responsible for infertility. As a reminder, infertility is a major public health issue and affects more and more couples around the world.
The investigators therefore wish to develop innovative tools to improve the diagnosis and management of hyperandrogenism
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
principal group
data collection
collection of data from medical records over a period of 5 years
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
collection of data from medical records over a period of 5 years
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering from hyperandrogenism
* Established etiological diagnosis with elimination of differential diagnoses
* Informed and not opposed to the collection of their data for the purposes of the study
Exclusion Criteria
* Patients under legal protection measures
16 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP251139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.